Big news in Alzheimer’s care: The FDA has just approved the first-ever blood test to help diagnose Alzheimer’s disease. 

This game-changing test measures specific proteins in the blood linked to early signs of Alzheimer’s, reducing the need for expensive PET scans or invasive spinal taps. It’s a simpler, less stressful option for patients showing signs of memory loss or cognitive decline, especially older adults.

While it’s not meant to be a stand-alone diagnostic tool, this blood test makes early detection more accessible and less intimidating. Combined with a full clinical evaluation, it’s a powerful new step toward faster answers, earlier support, and better planning for individuals and families. 

At Amicus Brain, we’re here to help you understand these advancements and navigate the diagnostic journey. Our digital advisors can provide clarity and support as you discuss these options with healthcare professionals. Learn more at www.amicusbrain.com.